Delivery Order SPE2DR25D1053-SPE2DR26FT469
Award Date 10/30/25
Potential Completion Date 10/31/25
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $6,890.00 delivery order to AmerisourceBergen Drug Corp for VEMLIDY 25 mg tablets (30-count units) on September 3, 2025, with a completion date of September 4, 2025. This firm fixed-price delivery order represents a pediatric delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The contract was competitively awarded with...
- The Defense Logistics Agency awarded a delivery order valued at $3,164.34 to AmerisourceBergen Drug Corp for VEMLIDY 25 mg tablets (30-count units) on August 11, 2025, with a completion date of August 12, 2025. This firm fixed price delivery order represents a non-competitive award under the vendor's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,643.00 for VEMLIDY 25 mg tablets (30-count units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract represents a non-competitive delivery order utilizing the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The award is performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, and...
- The Defense Logistics Agency awarded a delivery order valued at $33,916.69 to AmerisourceBergen Drug Corp for VEMLIDY 25 mg tablets (30-count units) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price contract, which is not set-aside, represents a pharmaceutical supply delivery supporting federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VEMLIDY 25 MG TABLET UU 30S. The $4,470.24 contract has a completion date of February 23, 2024. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug...
- The Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order for VEMLIDY 25MG tablets (30-count packages) valued at $52,588.54 on June 18, 2025, with an ultimate completion date of July 17, 2025. This firm fixed-price, non-set-aside award represents a competitive procurement of pharmaceutical products to support federal medical needs. The contract is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,206,161 units of the pharmaceutical product VEMLIDY 25 MG TABLET in 30-count packages. The $5,193.06 delivery order has a performance period through April 9, 2024. This award is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of up to $999,999,999.00...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,906.73 firm fixed price delivery order is for the supply of VEMLIDY 25 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of VEMLIDY 25 mg tablets, a pharmaceutical product. The contract has a firm fixed price of $13,155.76 and a period of performance ending on September 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEMLIDY 25 MG TABLET UU 30S. The award, valued at $74,288.73, has a completion date of June 23, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December...